% 0期刊文章%一个萨拉·海曼%瑞秋肯尼% Samarah Ahmed %一个雪莉Fung %阿齐兹Seixas % Girardin jean - louis %一个劳拉Balcer史蒂文Galetta % % Sujata Thawani % T纵向随访的头痛急性后遗症的上下文中COVID-19 (PASC)门诊神经组(p3 - 12.001) % D R 10.1212 / WNL 2023%。首页0000000000204315 % J首页神经病学% P V 100% N 17补充2% 4932% X目的:我们头痛症状的进化特征,自我感觉恢复non-hospitalized COVID-19“长搬运工”12个月后他们最初Neuro-COVID-19基线研究评估。背景:神经学家看到许多患者PASC头痛是最常见的一种症状。目前尚不清楚他们持续多久,以及他们如何影响生活质量。设计/方法:在后续的研究中一个基线群SARS-CoV-2 laboratory-positive病人评估之间的PASC 11月,2020年8月,2021年,49.5%(46/93)参与者完成随访电话问卷调查对他们的神经症状,头痛,复苏的主观印象,和生活质量。预防措施包括美国偏头痛患病率(AMPP),神经紊乱的生活质量(NeuroQoL)疲劳、焦虑、抑郁,头痛冲击试验(HIT6)。结果:症状出现COVID-19以来的平均时间为25.82个月(范围-30.35个月= 4.55)和37%的参与者是男性。47.8%有神经系统障碍,19.6%有偏头痛病史。使用混合效应模型调整了年龄、性别、和偏头痛的历史,占访问之间的相关性在基线和随访,T Neuro-QoL焦虑得分无显著差异(p = 0.30),抑郁T指数(p = 0.16),疲劳T指数(p > 0.05),头痛天数在过去的一个月(p > 0.05)之间的基线和1年随访。然而,差异被发现在HIT6得分之间的基线和1年随访(平均+ 3,p < 0.0001)。没有发现差异之间的分数前偏头痛和那些没有(p < 0.0001,线性回归)。结论:头痛的影响对个人遭受头痛的增加,和生活质量的措施和头痛的日子与基线相比并没有改变。这表明,生命质量和频率的头痛继续与PASC是一个挑战为个人和继续监测和治疗这些患者是十分必要的。披露:海曼女士没有披露。 Rachel Kenney has nothing to disclose. Ms. Ahmed has nothing to disclose. Ms. Fung has nothing to disclose. Azizi Seixas has nothing to disclose. Girardin Jean-Louis has nothing to disclose. Dr. Galetta has nothing to disclose. An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children’s Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society. Dr. Thawani has nothing to disclose. %U